PUBLISHER: TechNavio | PRODUCT CODE: 2005579
PUBLISHER: TechNavio | PRODUCT CODE: 2005579
Global Cytology Market 2026-2030
The global cytology market is forecasted to grow by USD 2450.8 mn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global cytology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer and infectious diseases, technological advancements in cytology and laboratory automation, rising awareness and expansion of population-based screening programs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7% |
| CAGR | 7.5% |
| Incremental Value | $2450.8 mn |
Technavio's global cytology market is segmented as below:
By End-User
- Hospitals
- Research laboratories and academic institutions
- Others
By Technique
- Liquid-based cytology
- Conventional cytology
By Application
- Cervical cancer screening
- Non-cervical cancer screening
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of digital pathology and artificial intelligence as one of the prime reasons driving the global cytology market growth during the next few years. Also, increasing emphasis on molecular cytology and ancillary testing and growing adoption of automation and workflow optimization in laboratories will lead to sizable demand in the market.
The report on the global cytology market covers the following areas:
- Global cytology market sizing
- Global cytology market forecast
- Global cytology market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cytology market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocare Medical LLC, CellaVision, COPAN Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Hologic Inc., IDEXX Laboratories Inc., Inpeco SA, Koninklijke Philips NV, QIAGEN N.V., Sakura Finetek, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare. Also, the global cytology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technique
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Cytology Market 2020 - 2024
- Historic Market Size - Data Table on Global Cytology Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Technique segment analysis 2020 - 2024
- Historic Market Size - Technique Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global cytology market
- 6.2 Impact of geopolitical conflicts on global cytology market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2025-2030
- 8.4 Research laboratories and academic institutions - Market size and forecast 2025-2030
- 8.5 Others - Market size and forecast 2025-2030
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Technique
- 9.1 Market segments
- 9.2 Comparison by Technique
- 9.3 Liquid-based cytology - Market size and forecast 2025-2030
- 9.4 Conventional cytology - Market size and forecast 2025-2030
- 9.5 Market opportunity by Technique
- Market opportunity by Technique ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Cervical cancer screening - Market size and forecast 2025-2030
- 10.4 Non-cervical cancer screening - Market size and forecast 2025-2030
- 10.5 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 South Africa - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.6 Argentina - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of cancer and infectious diseases
- Technological advancements in cytology and laboratory automation
- Rising awareness and expansion of population-based screening programs
- 13.2 Market challenges
- Acute shortage of skilled cytotechnologists and pathologists
- Competition from alternative and advanced diagnostic technologies
- High capital costs and reimbursement hurdles for advanced systems
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of digital pathology and artificial intelligence
- Increasing emphasis on molecular cytology and ancillary testing
- Growing adoption of automation and workflow optimization in laboratories
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.6 Biocare Medical LLC
- Biocare Medical LLC - Overview
- Biocare Medical LLC - Product / Service
- Biocare Medical LLC - Key offerings
- SWOT
- 15.7 CellaVision
- CellaVision - Overview
- CellaVision - Product / Service
- CellaVision - Key offerings
- SWOT
- 15.8 COPAN Diagnostics Inc.
- COPAN Diagnostics Inc. - Overview
- COPAN Diagnostics Inc. - Product / Service
- COPAN Diagnostics Inc. - Key offerings
- SWOT
- 15.9 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Business segments
- Hologic Inc. - Key offerings
- Hologic Inc. - Segment focus
- SWOT
- 15.12 IDEXX Laboratories Inc.
- IDEXX Laboratories Inc. - Overview
- IDEXX Laboratories Inc. - Business segments
- IDEXX Laboratories Inc. - Key offerings
- IDEXX Laboratories Inc. - Segment focus
- SWOT
- 15.13 Inpeco SA
- Inpeco SA - Overview
- Inpeco SA - Product / Service
- Inpeco SA - Key offerings
- SWOT
- 15.14 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.15 Sakura Finetek
- Sakura Finetek - Overview
- Sakura Finetek - Product / Service
- Sakura Finetek - Key offerings
- SWOT
- 15.16 Sysmex Corporation
- Sysmex Corporation - Overview
- Sysmex Corporation - Business segments
- Sysmex Corporation - Key news
- Sysmex Corporation - Key offerings
- Sysmex Corporation - Segment focus
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 Trivitron Healthcare
- Trivitron Healthcare - Overview
- Trivitron Healthcare - Product / Service
- Trivitron Healthcare - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
